Ardent Health Partners, LLC (NYSE:ARDT) Given Average Rating of “Buy” by Brokerages

Ardent Health Partners, LLC (NYSE:ARDT) has been assigned an average rating of “Buy” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $20.58.

Several research firms have recently weighed in on ARDT. Truist Financial reduced their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, January 6th. Stephens reiterated an “overweight” rating and issued a $22.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, April 1st. Guggenheim began coverage on shares of Ardent Health Partners in a research report on Wednesday, April 9th. They set a “buy” rating and a $16.00 target price on the stock. Royal Bank of Canada cut their target price on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Tuesday, March 4th. Finally, Mizuho dropped their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 9th.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. State Street Corp acquired a new position in Ardent Health Partners during the 3rd quarter worth approximately $1,977,000. Jane Street Group LLC acquired a new position in Ardent Health Partners during the third quarter worth $567,000. Barclays PLC purchased a new position in Ardent Health Partners in the third quarter worth $385,000. Geode Capital Management LLC acquired a new stake in Ardent Health Partners in the third quarter valued at $2,581,000. Finally, JPMorgan Chase & Co. purchased a new stake in shares of Ardent Health Partners during the 3rd quarter worth $154,000.

Ardent Health Partners Trading Up 1.6 %

ARDT stock opened at $12.50 on Friday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners has a twelve month low of $11.60 and a twelve month high of $20.72. The company’s 50 day moving average is $13.61 and its two-hundred day moving average is $15.57.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion. As a group, equities research analysts expect that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.